MEDIA

NEWS ARCHIVES

Tom Reeves leads the team of scientists and engineers at Interface Biologics - a privately held early commercial stage company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices.
See pg

Tom Reeves leads the team of scientists and engineers at Interface Biologics - a privately held early commercial stage company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices.